Source: Annual Congress 2002 - Thoracic oncology: biology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. Galffy, A. Lantos, L. Tamasi, V. B. Antony, P. Magyar (Budapest, Hungary; Indianapolis, United States Of America). Alteration of neutrophil invasion toward malignant mesothelioma by Interleukin-10. Eur Respir J 2002; 20: Suppl. 38, 1512

Member's Comments

No comment yet.

Related content which might interest you: All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice Source: Eur Respir J 2009; 34: 1159-1167 Year: 2009 Interleukin-8 and other mediators are related to tumour burden in malignant pleural effusions (MPE) Source: Eur Respir J 2007; 30: Suppl. 51, 103s Year: 2007 Tumor-derived monocyte chemoattractant protein-1 promotes malignant pleural effusion Source: Eur Respir J 2007; 30: Suppl. 51, 290s Year: 2007 Targeting of CSF1R abrogates Lewis Lung adenocarcinoma-induced malignant pleural effusion Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 Tumour necrosis correlates with angiogenesis and is a prognostic factor in malignant mesothelioma Source: Eur Respir J 2002; 20: Suppl. 38, 232s Year: 2002 CXCL12 expression in malignant mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007 Talc mediates angiostasis in malignant pleural effusions via endostatin induction Source: Eur Respir J 2007; 29: 761-769 Year: 2007 Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma in lung cancer complicated with metastatic pleurisy Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001 Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion Source: Eur Respir J 2009; 34: 184-190 Year: 2009 Predictive value of pro-inflammatory cytokine and pro-angiogenic factor in differentiating malignant from benign exudative effusion Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 The value of IL6 in differentiation between malignant and non malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Host-derived osteopontin is important for malignant pleural effusion formation Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008 A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma Source: Eur Respir J 2010; 36: 1099-1105 Year: 2010 ADAM10 membrane-bound protease mediates malignant pleural mesothelioma invasiveness Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 Non-classical monocytes potentiates the pathogenesis of malignant pleural effusion via the production of IL-1ß Source: International Congress 2019 – Biology of lung cancer Year: 2019 Association between proinflammatory cytokines (TNFa and IL8) and fibrinolytic system in malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 494s Year: 2004 The role of monocyte chemoattractant protein-1 (MCP-1) in the development of malignant pleural effusion Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease Year: 2021 Osteopontin is important for malignant pleural effusion formation Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Tumour-associated macrophages in nonsmall cell lung cancer: the role of interleukin-10 Source: Eur Respir J 2007; 30: 608-610 Year: 2007 Mast cells recruitment to malignant pleural effusions Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010